Linked Life Data

18035413

Source:http://linkedlifedata.com/resource/pubmed/id/18035413

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18035413rdf:typepubmed:Citationlld:pubmed
pubmed-article:18035413lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0152035lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0023467lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0919534lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C1333715lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C2825097lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C0678951lld:lifeskim
pubmed-article:18035413lifeskim:mentionsumls-concept:C1515568lld:lifeskim
pubmed-article:18035413pubmed:issue8lld:pubmed
pubmed-article:18035413pubmed:dateCreated2008-5-7lld:pubmed
pubmed-article:18035413pubmed:abstractTextWe investigated the prognostic significance of genetic polymorphism for glutathione S-transferase theta 1 (GSTT1) and glutathione S-transferase mu 1 (GSTM1) in 254 Chinese patients with de novo acute myeloid leukemia (AML) other than AML-M3. The early death rate after the initiation of chemotherapy was similar between the GSTT1+/GSTM1+ group and GSTT1-/GSTM1- group. The complete remission (CR) rate was higher in GSTM1+ group than in GSTM1- group (OR=1.88; P=0.03) after the first course of chemotherapy, and was higher in GSTT1+ group than in GSTT1- group (OR=2.20; P=0.02) after the second course of chemotherapy. Overall survival and disease-free survival of CR patients in GSTT1 and GSTM1 double present group was better than in GSTT1- and/or GSTM1-group (P=0.03 and 0.02, respectively). Our preliminary results warrant testing of a larger number of patients.lld:pubmed
pubmed-article:18035413pubmed:languageenglld:pubmed
pubmed-article:18035413pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18035413pubmed:citationSubsetIMlld:pubmed
pubmed-article:18035413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18035413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18035413pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18035413pubmed:statusMEDLINElld:pubmed
pubmed-article:18035413pubmed:monthAuglld:pubmed
pubmed-article:18035413pubmed:issn0145-2126lld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:JooFFlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:WangJianxiang...lld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:YangLinLlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:HaoYushuYlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:XiaoZhijianZlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:ZhangYueYlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:LiuLiangLlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:XuZefengZlld:pubmed
pubmed-article:18035413pubmed:authorpubmed-author:NieLingLlld:pubmed
pubmed-article:18035413pubmed:issnTypePrintlld:pubmed
pubmed-article:18035413pubmed:volume32lld:pubmed
pubmed-article:18035413pubmed:ownerNLMlld:pubmed
pubmed-article:18035413pubmed:authorsCompleteYlld:pubmed
pubmed-article:18035413pubmed:pagination1288-91lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:meshHeadingpubmed-meshheading:18035413...lld:pubmed
pubmed-article:18035413pubmed:year2008lld:pubmed
pubmed-article:18035413pubmed:articleTitleGlutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia.lld:pubmed
pubmed-article:18035413pubmed:affiliationState Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. zjxiao@hotmail.comlld:pubmed
pubmed-article:18035413pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18035413pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2944entrezgene:pubmedpubmed-article:18035413lld:entrezgene
entrez-gene:2952entrezgene:pubmedpubmed-article:18035413lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18035413lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18035413lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18035413lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18035413lld:entrezgene